Oncomodulation by human cytomegalovirus: Novel clinical findings open new roads

Medical Microbiology and Immunology

Volumn 200, Issue 1, 2011, Pages 1-5

  Michaelis, Martin ^a   Baumgarten, Peter ^b   Mittelbronn, Michel ^b   Driever, Pablo Hernáiz ^c   Doerr, Hans Wilhelm ^a   Cinatl Jr , Jindrich ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer; Cytomegalovirus; Glioblastoma; Neuroblastoma; Oncomodulation; Tumour virus

Indexed keywords

CELL PROTEIN; VIRUS PROTEIN;

CANCER GROWTH; DISEASE COURSE; GLIOBLASTOMA; HUMAN; HUMAN CYTOMEGALOVIRUS; ONCOGENESIS AND MALIGNANT TRANSFORMATION; ONCOMODULATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PUBLICATION; REVIEW; VIRUS DETECTION;

CYTOMEGALOVIRUS; GLIOBLASTOMA; HOST-PATHOGEN INTERACTIONS; HUMANS; NEOPLASMS; VIRAL PROTEINS;

EID: 78751637555     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-010-0177-7     Document Type: Review

References (60)

1. J M'Fadyan F Hobday 1898 Note on the experimental transmission of warts in the dog J Comp Pathol Ther 11 341 343
2. G Ciuffo 1907 Innesto positivo con filtrato di verruca volgare Giorn Ital Mal Venereol 48 12 17
3. V Ellermann O Bang 1908 Experimentelle Leukämie bei Hühnern Zentralbl Bakteriol Abt I Orig 46 595 609
4. P Rous 1911 Transmission of a malignant new growth by means of a cell-free filtrate Am J Med Assoc 56 198
5. RT Javier JS Butel 2008 The history of tumor virology Cancer Res 68 7693 7706 1:CAS:528:DC%2BD1cXhtF2msL7L 10.1158/0008-5472.CAN-08-3301 18829521
6. ME McLaughlin-Drubin K Munger 2008 Viruses associated with human cancer Biochim Biophys Acta 1782 127 150 1:CAS:528:DC%2BD1cXitVGnurY%3D 18201576
7. E Kelly SJ Russell 2007 History of oncolytic viruses: genesis to genetic engineering Mol Ther 15 651 659 1:CAS:528:DC%2BD2sXhtVejtb7F 10.1038/sj.mt.6300033 17299401 (Pubitemid 46043667)
8. F Halary V Pitard D Dlubek R Krzysiek H de la Salle P Merville C Dromer D Emilie JF Moreau J Déchanet-Merville 2005 Shared reactivity of Vdelta2(neg) gammadelta T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells J Exp Med 201 1567 1578 1:CAS:528: DC%2BD2MXktlygu7k%3D 10.1084/jem.20041851 15897274 (Pubitemid 40721002)
9. C Devaud E Bilhere S Loizon V Pitard C Behr JF Moreau J Dechanet-Merville M Capone 2009 Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model Cancer Res 69 3971 3978 1:CAS:528:DC%2BD1MXltFOksbg%3D 10.1158/0008-5472.CAN-08-3037 19383918
10. L Couzi Y Levaillant A Jamai V Pitard R Lassalle K Martin I Garrigue O Hawchar F Siberchicot N Moore JF Moreau J Dechanet-Merville P Merville 2010 Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation J Am Soc Nephrol 21 181 188 1:CAS:528: DC%2BC3cXhsFClurg%3D 10.1681/ASN.2008101072 19713314
11. KC Erlach V Böhm M Knabe P Deegen MJ Reddehase J Podlech 2008 Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection Med Microbiol Immunol 197 167 178 1:CAS:528:DC%2BD1cXkslKiu7k%3D 10.1007/s00430-008-0084-3 18309517
12. M Michaelis HW Doerr J Cinatl Jr 2009 The story of human cytomegalovirus and cancer: increasing evidence and open questions Neoplasia 11 1 9 1:CAS:528:DC%2BD1MXhvVOls7w%3D 19107226
13. J Cinatl Jr J Cinatl K Radsak H Rabenau B Weber M Novak R Benda B Kornhuber HW Doerr 1994 Replication of human cytomegalovirus in a rhabdomyosarcoma cell line depends on the state of differentiation of the cells Arch Virol 138 391 401 1:CAS:528:DyaK2MXivVSlt70%3D 10.1007/BF01379143 7998845
14. Cinatl J Jr, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW (1996) Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 39:259-269
15. J Cinatl Jr JU Vogel J Cinatl B Weber H Rabenau M Novak B Kornhuber HW Doerr 1996 Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line Int J Cancer 65 90 96 10.1002/(SICI)1097-0215(19960103) 65:1<90::AID-IJC16>3.0.CO;2-M 8543403 (Pubitemid 26027541)
16. J Cinatl Jr J Cinatl JU Vogel R Kotchetkov PH Driever H Kabickova B Kornhuber D Schwabe HW Doerr 1998 Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells Cancer Res 58 367 372 1:CAS:528:DyaK1cXnt1aquw%3D%3D 9443419
17. J Cinatl Jr R Kotchetkov M Scholz J Cinatl JU Vogel PH Driever HW Doerr 1999 Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53 Am J Pathol 155 285 292 1:CAS:528:DyaK1MXkslegtbk%3D 10393860
18. J Cinatl Jr M Scholz HW Doerr 2005 Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation Med Res Rev 25 167 185 1:CAS:528:DC%2BD2MXitlWhs7c%3D 10.1002/med.20018 15389728 (Pubitemid 40299845)
19. M Michaelis HW Doerr J Cinatl Jr 2009 Oncomodulation by human cytomegalovirus: evidence becomes stronger Med Microbiol Immunol 198 79 81 10.1007/s00430-009-0107-8 19198878
20. M Ho 2008 The history of cytomegalovirus and its diseases Med Microbiol Immunol 197 65 73 10.1007/s00430-007-0066-x 18087722
21. K Besold B Plachter 2008 Recombinant viruses as tools to study human cytomegalovirus immune modulation Med Microbiol Immunol 197 215 222 10.1007/s00430-008-0083-4 18301917
22. V Böhm J Podlech D Thomas P Deegen MF Pahl-Seibert NA Lemmermann NK Grzimek SA Oehrlein-Karpi MJ Reddehase R Holtappels 2008 Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy Med Microbiol Immunol 197 135 144 10.1007/s00430-008-0092-3 18340461
23. AE Campbell VJ Cavanaugh JS Slater 2008 The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence Med Microbiol Immunol 197 205 213 10.1007/s00430-008-0077-2 18259775
24. CM Doom AB Hill 2008 MHC class I immune evasion in MCMV infection Med Microbiol Immunol 197 191 204 1:CAS:528:DC%2BD1cXkslKhsr4%3D 10.1007/s00430-008-0089-y 18330598
25. F Grey L Hook J Nelson 2008 The functions of herpesvirus-encoded microRNAs Med Microbiol Immunol 197 261 267 1:CAS:528:DC%2BD1cXkslKiu7o%3D 10.1007/s00430-007-0070-1 18087721
26. R Holtappels V Böhm J Podlech MJ Reddehase 2008 CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model Med Microbiol Immunol 197 125 134 10.1007/s00430-008-0093-2 18343947
27. T Lenac J Arapović L Traven A Krmpotić S Jonjić 2008 Murine cytomegalovirus regulation of NKG2D ligands Med Microbiol Immunol 197 159 166 10.1007/s00430-008-0080-7 18259774
28. H Martin M Mandron C Davrinche 2008 Interplay between human cytomegalovirus and dendritic cells in T cell activation Med Microbiol Immunol 197 179 184 10.1007/s00430-008-0079-0 18264717
29. GG Maul D Negorev 2008 Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle Med Microbiol Immunol 197 241 249 10.1007/s00430-008-0078-1 18264718
30. C Powers K Früh 2008 Rhesus CMV: an emerging animal model for human CMV Med Microbiol Immunol 197 109 115 10.1007/s00430-007-0073-y 18193454
31. T Sacher S Jordan CA Mohr A Vidy AM Weyn Z Ruszics UH Koszinowski 2008 Conditional gene expression systems to study herpesvirus biology in vivo Med Microbiol Immunol 197 269 276 1:CAS:528:DC%2BD1cXkslKiu7c%3D 10.1007/s00430-008-0086-1 18324415
32. CK Seckert A Renzaho MJ Reddehase NK Grzimek 2008 Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection Med Microbiol Immunol 197 251 259 10.1007/s00430-008-0094-1 18365252
33. MF Stinski H Isomura 2008 Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency Med Microbiol Immunol 197 223 231 10.1007/s00430-007-0069-7 18097687
34. L von Müller T Mertens 2008 Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression Med Microbiol Immunol 197 75 82 10.1007/s00430-008-0087-0
35. EC Waller E Day JG Sissons MR Wills 2008 Dynamics of T cell memory in human cytomegalovirus infection Med Microbiol Immunol 197 83 96 10.1007/s00430-008-0082-5 18301918
36. AP Limaye KA Kirby GD Rubenfeld WM Leisenring EM Bulger MJ Neff NS Gibran ML Huang TK Santo Hayes L Corey M Boeckh 2008 Cytomegalovirus reactivation in critically ill immunocompetent patients JAMA 300 413 422 1:CAS:528: DC%2BD1cXovFSqt7s%3D 10.1001/jama.300.4.413 18647984 (Pubitemid 352040253)
37. C Söderberg-Nauclér 2008 HCMV microinfections in inflammatory diseases and cancer J Clin Virol 41 218 223 10.1016/j.jcv.2007.11.009 18164235
38. J Cinatl Jr JU Vogel R Kotchetkov H Wilhelm Doerr 2004 Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression FEMS Microbiol Rev 28 59 77 1:CAS:528:DC%2BD2cXht1yrtr4%3D 10.1016/j.femsre.2003.07.005 14975530 (Pubitemid 38224507)
39. C Paulus A Nitzsche M Nevels 2010 Chromatinisation of herpesvirus genomes Rev Med Virol 20 34 50 1:CAS:528:DC%2BC3cXit1Gmurs%3D 10.1002/rmv.632 19890944
40. SS Terhune NJ Moorman IM Cristea JP Savaryn C Cuevas-Bennett MP Rout BT Chait T Shenk 2010 Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA PLoS Pathog 6 e1000965 10.1371/journal.ppat.1000965 20585571
41. J Komano M Sugiura K Takada 1998 Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata J Virol 72 9150 9156 1:CAS:528:DyaK1cXmslahs7Y%3D 9765461
42. J Kassis A Maeda N Teramoto K Takada C Wu G Klein A Wells 2002 EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness Int J Cancer 99 644 651 1:CAS:528:DC%2BD38Xkt1Slsr4%3D 10.1002/ijc.10382 12115496 (Pubitemid 34538742)
43. B Abdulkarim S Sabri D Zelenika E Deutsch V Frascogna J Klijanienko W Vainchenker I Joab J Bourhis 2003 Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies Oncogene 22 2260 2271 1:CAS:528:DC%2BD3sXivFGktL0%3D 10.1038/sj.onc.1206402 12700662 (Pubitemid 36566782)
44. SK Lau YY Chen WG Chen DJ Diamond AN Mamelak JA Zaia LM Weiss 2005 Lack of association of cytomegalovirus with human brain tumors Mod Pathol 18 838 843 1:CAS:528:DC%2BD2MXktlWitLw%3D 10.1038/modpathol.3800352 15578071 (Pubitemid 40780518)
45. S Poltermann B Schlehofer K Steindorf P Schnitzler K Geletneky JR Schlehofer 2006 Lack of association of herpesviruses with brain tumors J Neurovirol 12 90 99 1:STN:280:DC%2BD28zot1agtQ%3D%3D 10.1080/13550280600654573 16798670 (Pubitemid 44574600)
46. J Sabatier E Uro-Coste I Pommepuy F Labrousse S Allart M Trémoulet MB Delisle P Brousset 2005 Detection of human cytomegalovirus genome and gene products in central nervous system tumours Br J Cancer 92 747 750 1:CAS:528:DC%2BD2MXhsFWlt74%3D 10.1038/sj.bjc.6602339 15700045 (Pubitemid 40460613)
47. Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, Fraile-Ramos A, Lira SA, Söderberg-Nauclér C, Smit MJ (2010) HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 3:ra58
48. Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C (2010) The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol 2010 Sep 5. [Epub ahead of print]
49. K Strååt C Liu A Rahbar Q Zhu L Liu N Wolmer-Solberg F Lou Z Liu J Shen J Jia S Kyo M Björkholm J Sjöberg C Söderberg- Nauclér D Xu 2009 Activation of telomerase by human cytomegalovirus J Natl Cancer Inst 101 488 497 10.1093/jnci/djp031 19318640
50. CS Cobbs L Harkins M Samanta GY Gillespie S Bharara PH King LB Nabors CG Cobbs WJ Britt 2002 Human cytomegalovirus infection and expression in human malignant glioma Cancer Res 62 3347 3350 1:CAS:528:DC%2BD38XkslWqsL4%3D 12067971
51. DA Mitchell W Xie R Schmittling C Learn A Friedman RE McLendon JH Sampson 2008 Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma Neuro Oncol 10 10 18 10.1215/15228517-2007-035 17951512 (Pubitemid 351250896)
52. ME Scheurer ML Bondy KD Aldape T Albrecht R El-Zein 2008 Detection of human cytomegalovirus in different histological types of gliomas Acta Neuropathol 116 79 86 1:CAS:528:DC%2BD1cXosVOjtLk%3D 10.1007/s00401-008-0359-1 18351367
53. J Cinatl Jr M Nevels C Paulus M Michaelis 2009 Activation of telomerase in glioma cells by human cytomegalovirus: another piece of the puzzle J Natl Cancer Inst 101 441 443 1:CAS:528:DC%2BD1MXktFWrtbg%3D 10.1093/jnci/djp047 19318630
54. RM Prins TF Cloughesy LM Liau 2008 Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate N Engl J Med 359 539 541 1:CAS:528:DC%2BD1cXpt1SgsLs%3D 10.1056/NEJMc0804818 18669440
55. J Aarnisalo J Ilonen R Vainionpää I Volanen T Kaitosaari O Simell 2003 Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first 8 years of life: a prospective study Scand J Infect Dis 35 750 753 10.1080/00365540310015881 14606615 (Pubitemid 37336903)
56. P Wertheim PA Voute 1976 Neuroblastoma, Wilms' tumor, and cytomegalovirus J Natl Cancer Inst 57 701 703 1:STN:280:DyaE2s%2FjtFOksg%3D%3D 185403
57. G Nigro A Schiavetti JC Booth A Clerico C Dominici A Krzysztofiak M Castello 1995 Cytomegalovirus-associated stage 4S neuroblastoma relapsed stage 4 Med Pediatr Oncol 24 200 203 1:STN:280:DyaK2M7jvFyrtg%3D%3D 10.1002/mpo.2950240311 7838043
58. I Casciano K Mazzocco L Boni G Pagnan B Banelli G Allemanni M Ponzoni GP Tonini M Romani 2002 Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients Cell Death Differ 9 246 251 1:CAS:528:DC%2BD38XisVWmsLs%3D 10.1038/sj.cdd.4400993 11859407 (Pubitemid 34223868)
59. S Allart H Martin C Detraves J Terrasson D Caput C Davrinche 2002 Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha J Biol Chem 277 29063 29068 1:CAS:528:DC%2BD38XmsVKjs7k%3D 10.1074/jbc.M201974200 12034725
60. RA Blaheta WD Beecken T Engl D Jonas E Oppermann M Hundemer HW Doerr M Scholz J Cinatl Jr 2004 Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness Neoplasia 6 323 331 1:CAS:528:DC%2BD2cXmslWlurk%3D 10.1593/neo.03418 15256054 (Pubitemid 38924847)